Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size

BACKGROUND: The treatment schedules for stereotactic body radiotherapy (SBRT) for lung cancer vary from institution to institution. Several reports have indicated that stage IB patients had worse outcomes than stage IA patients when the same dose was used. We evaluated the clinical outcomes of SBRT...

Descripción completa

Detalles Bibliográficos
Autores principales: Baba, Fumiya, Shibamoto, Yuta, Ogino, Hiroyuki, Murata, Rumi, Sugie, Chikao, Iwata, Hiromitsu, Otsuka, Shinya, Kosaki, Katsura, Nagai, Aiko, Murai, Taro, Miyakawa, Akifumi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955592/
https://www.ncbi.nlm.nih.gov/pubmed/20849623
http://dx.doi.org/10.1186/1748-717X-5-81

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955592/
https://www.ncbi.nlm.nih.gov/pubmed/20849623
http://dx.doi.org/10.1186/1748-717X-5-81

Ejemplares similares